Cordant Inc’s HCA Healthcare HCA Stock Holding History

Cordant Inc’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13	Closed	-$3K	–	566
2022 Q1	$3K	Buy	+13	New	+$3.27K	﹤0.01%	480

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cordant Inc's HCA Position: Q2 2022 in Review

Cordant Inc sold out of HCA Healthcare (HCA) in Q2 2022, closing a stake of 13 shares — an estimated $3K sold.

Cordant Inc first reported a position in HCA in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 883 funds tracked by Wall St. Rank hold HCA as of Q2 2022.

Cordant Inc reported no remaining HCA Healthcare position as of Q2 2022 after selling out during the quarter.
Cordant Inc sold 13 HCA Healthcare shares in Q2 2022, an estimated $3K.
Cordant Inc first reported a position in HCA Healthcare in Q1 2022 and held it in 1 quarter.
Cordant Inc's HCA Healthcare position peaked at $3K in Q1 2022.
883 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.